Interface between authorship, industry and science in the domain of therapeutics

被引:125
作者
Healy, D [1 ]
Cattell, D [1 ]
机构
[1] Univ Wales, Coll Med, Dept Psychol Med, Bangor LL57 2PW, Gwynedd, Wales
关键词
D O I
10.1192/bjp.183.1.22
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Background Changes in the character of medical authorship. Aims To compare the impact of industry-l inked and non-industry I inked articles. Method We compared articles on sertraline being coordinated by a medical writing agency with articles not coordinated in this way. We calculated numbers of Medline-listed articles per author, journal impact factors, literature profiles and citation rates of both sets of articles. Results Non-agency-linked articles on sertraline had an average of 2.95 authors per article, a mean length of 3.4 pages, a mean Medline listing of 37 articles per author (95% Cl 27-47) and a mean literature profile of 283 per article (95% Cl 130-435). Agency-linked articles on sertraline had an average of 6.6 authors per article, a mean length of 10.7 pages, a mean Medline listing of 70 articles per author (95% Cl 62-79) and a mean literature profile of 1839 per article (95% Cl 1076-2602). The citation rate for agency articles was 20.2 (95% Cl 13.4-27.0) and for non-agency articles it was 3.7 (95% Cl 3.3-8.1). Conclusions The literature profiles and citation rates of industry-linked and non-industry-linked articles differ. The emerging style of authorship in industry linked articles can deliver good-quality articles, but it raises concerns for the. scientific base of therapeutics. Declaration of interest D.H. has had consultancies or other links with all major pharmaceutical companies.
引用
收藏
页码:22 / 27
页数:6
相关论文
共 14 条
[1]   Sertraline treatment of children and adolescents with obsessive-compulsive disorder or depression: Pharmacokinetics, tolerability and efficacy [J].
Alderman, J ;
Wolkow, R ;
Chung, M ;
Johnston, HF .
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 1998, 37 (04) :386-394
[2]   Sponsorship, authorship, and accountability. [J].
Davidoff, F ;
DeAngelis, CD ;
Drazen, JM ;
Hoey, J ;
Hojgaard, L ;
Horton, R ;
Kotzin, S ;
Nicholls, MG ;
Nylenna, M ;
Overbeke, AJPM ;
Sox, HC ;
Van Der Weyden, MB ;
Wilkes, MS .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (11) :825-827
[3]   Prevalence of articles with honorary authors and ghost authors in peer-reviewed medical journals [J].
Flanagin, A ;
Carey, LA ;
Fontanarosa, PB ;
Phillips, SG ;
Pace, BP ;
Lundberg, GD ;
Rennie, D .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (03) :222-224
[4]   Predictive value of pharmacological activity for the relative efficacy of antidepressant drugs - Meta-regression analysis [J].
Freemantle, N ;
Anderson, IM ;
Young, P .
BRITISH JOURNAL OF PSYCHIATRY, 2000, 177 :292-302
[5]   Publication bias and the integrity of psychiatry research [J].
Gilbody, SM ;
Song, FJ .
PSYCHOLOGICAL MEDICINE, 2000, 30 (02) :253-258
[6]   SSRIs and deliberate self-harm [J].
Healy, D .
BRITISH JOURNAL OF PSYCHIATRY, 2002, 180 :547-547
[7]  
Healy D., 2002, CREATION PSYCHOPHARM
[8]  
*INT COMM MED J ED, 2000, UN REQ MAN SUBM BIOM
[9]   Symptom reduction and suicide risk in patients treated with placebo in antidepressant clinical trials - An analysis of the food and drug administration database [J].
Khan, A ;
Warner, HA ;
Brown, WA .
ARCHIVES OF GENERAL PSYCHIATRY, 2000, 57 (04) :311-317
[10]   SSRI-induced extrapyramidal side-effects and akathisia: implications for treatment [J].
Lane, RM .
JOURNAL OF PSYCHOPHARMACOLOGY, 1998, 12 (02) :192-214